Announce Date | 02/28/2025 |
EPS Normalized Actual | $-0.16 (Miss by $-1.28) |
EPS GAAP Actual | $-0.16 (Miss by $-1.28) |
Revenue Actual | $617.347B |
Revenue Surprise | Beat by $617347M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $9.15 |
EPS GAAP Estimate | $9.15 |
Revenue Estimate | $2.3999775B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0 | INF | 0 | 0 | 0 |
Dec 2026 | 22.935 | 5.17 | 7.36 | 38.51 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.001 | -7.094 | 617.347B | -55.5% | 616573.75M |
FQ3 2024 (Sep 2024) | 0.29 | -1.25141 | 0.671897B | -10.41% | -811.74M |
FQ2 2024 (Jun 2024) | 4.53 | 4.53 | 0.803969B | -6.77% | 803.97M |
FQ1 2024 (Mar 2024) | 9.77 | 9.77 | 0.864072B | -5.46% | 864.07M |
FQ4 2023 (Dec 2023) | 12883 | 12883 | 959.991B | 99.91% | 959991M |
FQ3 2023 (Sep 2023) | 6.88 | 6.88 | 0.74182B | -17.25% | 741.82M |
FQ2 2023 (Jun 2023) | 12.63 | 12.63 | 0.858371B | 100% | 858.37M |
FQ1 2023 (Mar 2023) | 17.74 | 17.74 | 0.911235B | 100% | 911.24M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
9.15
Consensus Revenue Estimates
2.3999775B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 10.06 | -- | 9.77795 | 10.34205 | 0 |
FQ3 2026 (Jul 2026) | 10.06 | -- | 9.77795 | 10.34205 | 0 |
FQ2 2026 (Jun 2026) | 9.75 | -- | 9.62522 | 9.87478 | 0 |
FQ1 2026 (Mar 2026) | 9.38 | -- | 9.25996 | 9.50004 | 0 |
FQ4 2025 (Oct 2025) | 9.56 | 99.99 | 9.29197 | 9.82803 | 0 |
FQ3 2025 (Jul 2025) | 9.44 | 96.93 | 9.17533 | 9.70467 | 0 |
FQ2 2025 (Jun 2025) | 9.15 | 50.49 | 9.0329 | 9.2671 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 1.42B | -- | 1.39B | 1.45B | 0 |
FQ3 2026 (Jul 2026) | 1.35B | -- | 1.32B | 1.38B | 0 |
FQ2 2026 (Jun 2026) | 3.36B | -- | 3.33B | 3.39B | 0 |
FQ1 2026 (Mar 2026) | 3.12B | -- | 3.09B | 3.15B | 0 |
FQ4 2025 (Oct 2025) | 1.16B | -52992.66 | 1.14B | 1.19B | 0 |
FQ3 2025 (Jul 2025) | 1.11B | 39.28 | 1.08B | 1.13B | 0 |
FQ2 2025 (Jun 2025) | 2.4B | 66.5 | 2.38B | 2.42B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 7.095 | 0.001 | -7.094 | -709400% |
FQ3 2024 (Sep 2024) | 1.54141 | 0.29 | -1.25141 | -431.52% |
FQ2 2024 (Jun 2024) | 4.53 | 4.53 | 100% | |
FQ1 2024 (Mar 2024) | 9.77 | 9.77 | 100% | |
FQ4 2023 (Dec 2023) | 12883 | 12883 | 100% | |
FQ3 2023 (Sep 2023) | 6.88 | 6.88 | 100% | |
FQ2 2023 (Jun 2023) | 12.63 | 12.63 | 100% | |
FQ1 2023 (Mar 2023) | 17.74 | 17.74 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0.77B | $617.35B | $616573.75M | 99.87% |
FQ3 2024 (Sep 2024) | $1.48B | $0.67B | $-811.74M | -120.81% |
FQ2 2024 (Jun 2024) | $0B | $0.8B | $803.97M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.86B | $864.07M | 100% |
FQ4 2023 (Dec 2023) | $0B | $959.99B | $959991M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.74B | $741.82M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.86B | $858.37M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.91B | $911.24M | 100% |